LGT CAPITAL PARTNERS LTD. - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 303 filers reported holding HAEMONETICS CORP in Q1 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.

Quarter-by-quarter ownership
LGT CAPITAL PARTNERS LTD. ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$10,023,823
+5.2%
111,8980.0%0.36%
+9.7%
Q2 2023$9,526,996
-40.2%
111,898
-41.9%
0.33%
-25.7%
Q1 2023$15,925,982
-31.9%
192,459
-35.3%
0.44%
-35.2%
Q4 2022$23,396,723
-59.0%
297,479
-61.4%
0.68%
-60.8%
Q3 2022$57,076,000
-11.4%
770,989
-22.0%
1.74%
-10.9%
Q2 2022$64,408,000
+5.4%
988,149
+2.2%
1.96%
+12.8%
Q1 2022$61,102,000
-5.3%
966,499
-20.5%
1.74%
+1.3%
Q4 2021$64,500,000
-22.5%
1,216,059
+3.1%
1.72%
-31.7%
Q3 2021$83,272,000
+31.1%
1,179,659
+23.7%
2.51%
+39.6%
Q2 2021$63,536,000953,4251.80%
Other shareholders
HAEMONETICS CORP shareholders Q1 2023
NameSharesValueWeighting ↓
BEACONLIGHT CAPITAL, LLC 95,033$8,511,0002.84%
Advantage Alpha Capital Partners LP 100,170$8,971,0002.10%
Nitorum Capital, L.P. 395,635$35,433,0001.82%
Summit Creek Advisors LLC 127,600$11,428,0001.68%
Bridge City Capital, LLC 40,559$3,632,0001.67%
AEGON ASSET MANAGEMENT UK PLC 520,408$46,603,0001.05%
Jackson Square Partners, LLC 2,298,190$205,825,0001.03%
Parkman Healthcare Partners LLC 30,147$2,700,0000.76%
TEALWOOD ASSET MANAGEMENT INC 9,154$820,0000.54%
AMERICAN CAPITAL MANAGEMENT INC 159,145$14,253,0000.52%
View complete list of HAEMONETICS CORP shareholders